| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| Wright Medical Group, Inc. |
| 5677 Airline Road, Arlington, TN 38002 * (901) 867-9971 |
| Business Description | The company is a global orthopaedic device company specializing in the design, manufacture and marketing of reconstructive joint devices and bio-orthopaedic materials. |
| Offering Information Company has | |||
| Trading As | WMGI (NASNTL) | Industry | Manufacturing (SIC 3841) |
| Type of Stock Offered | Common Shares | Filing Date | 4/27/2001 |
| Domestic Shares Offered | 7,500,000 | Offer Date | 7/12/2001 |
| Foreign Shares Offered | 0 | Filing Range | $11.50 - $13.50 |
| Company Shares | 7,500,000 | Offer Price | $12.50 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.875 |
| Gross Proceeds | $93,750,000 | Selling | $0.525 |
| Expenses | $1,800,000 | Reallowance | $0.100 |
| Post-IPO Shares | 27,980,000 | Employees | 671 |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| J.P. Morgan & Co. | Lead Manager | (212) 648-0517 |
| CS First Boston | Co-manager | (212) 325-2000 |
| U.S. Bancorp Piper Jaffray | Co-manager | (612) 342-6220 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | - - Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1998 | 12/31/1999 | 12/31/2000 | ||||
| Revenues | - | - | 106.972 | 109.170 | 157.552 | - | - |
| Income from Oper. | - | - | -8.741 | -24.402 | -24.636 | - | - |
| Net Income | - | - | -24.171 | -40.355 | -39.493 | - | - |
| E.P.S | - | - | - | - | - | - | - |
| Revenue Growth (%) | - | - | 2.05 | 44.318 | - | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | 25.20 | - | - | ||||
| Cash Flow - Inv. | 18.15 | - | - | ||||
| Cash Flow - Fin. | -14.11 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/2000 | Financial Ratios | ||||
| Total Assets | 216.96 | Current Assets | 115.19 | Current Ratio | 1.88 |
| Total Liab. | 293.94 | Current Liab. | 61.17 | Debt Ratio | 135.48% |
| Total Equity | -76.98 | Working Cap. | 54.02 | Debt to Equity Ratio | - |
| Cash | 16.30 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to repay outstanding indebtedness and for general corporate purposes including to fund working capital, future product development and acquisition of technologies, products and companies. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Willkie Farr & Gallagher |
| Bank's Law Firm | Milbank, Tweed, Hadley & McCloy |
| Registrar/Transfer Agent | American Stock Transfer & Trust Co |
| Auditor | Arthur Andersen |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Warburg, Pincus Equity Partners, L.P. | 81.55 | |
| California Public Employees' Retirement System | 7.70 | |
| Vertical Fund Associates, L.P. | 5.33 | |
| Note: represents ownership of 5% or more prior to the offering. | ||